Friday, 17 Jan 2020

You are here

Improved Survival with Renal Transplant in SLE

The Annals of Internal Medicine has published a cohort study of lupus nephritis (LN) patients with end-stage renal disease (ESRD), showing that renal transplantation is associated with improved survival benefit, with a reduction in death from cardiovascular (CV) disease and infection.

A nationwide cohort study analyzed the national database of nearly all patients with ESRD (United States Renal Data System) and looked at those with incident LN-ESRD who were waitlisted for a renal transplant.

Of the 9659 patients with wait-listed LN-ESRD, 5738 (59%) had a renal transplant.

Transplantation was associated with a reduction in:

  • All-cause mortality (adjusted HR, 0.30 [95% CI, 0.27 to 0.33])
  • CV death (adj. HR 0.26 [CI, 0.23 to 0.30]
  • Death from coronary heart disease 0.30 (CI, 0.19 to 0.48) for ,
  • Death from infection 0.41 (CI, 0.32 to 0.52)
  • Death from Sepsis (aHR 0.41 (CI, 0.31 to 0.53) 

Renal transplant was associated with a significant survival benefit and highlights the benefit of timely referral for LN-ESRD patients needing transplantation.

The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

TULIP2 - Anifrolumab Succeeds in Lupus

NEJM has published the results of the TULIP2 trial with anifrolumab, an alpha interferon blocker, in the treatment of systemic lupus erythematosus, showing significant improvement (over placebo) in multiple lupus outcome measures, including BICLA, SRI-4, CLASI and others.

Steroids Up the Risk of Organ Damage in SLE

Lancet Rheumatology has reported the results of a multicenter follow-up study of systemic lupus erythematosus (SLE) patients showing that organ damange is linked to glucocorticoid use, independent of clinical or serological disease activity.

Treatment of Statin-induced anti-HMGCR myopathy

Statin-induced myositis, often with anti-HMGCR autoantibodies can be difficult to manage, Arthritis Research & Therapy yhas published the experience of 55 patient with HMGCR myopathy, demonstrating that while steroid management may be reasonable in select patients, the use of triple steroid/IVIG/SSI was very efficacious in induction.

Best of 2019 - 2019 EULAR Guidelines on Antiphospholipid Syndrome Management

A EULAR task force has reviewed the medical literature and developed evidence-based recommendations for the management of antiphospholipid syndrome (APS) in adults. They note that a high-risk antiphospholipid antibody (aPL) profile is associated with greater risk for thrombotic and obstetric APS.

Best of 2019 - New EULAR/ACR Classification Criteria for SLE

The European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) have jointly developed new classification criteria for systemic lupus erythematosus (SLE); prompted by the need for criteria that were both highly sensitive and specific. The net result is improved sensitivity and specificity, but the use of positive ANA requirement along with a longer list of weighted criteria ensures its utility in SLE research (including early or latent SLE), but not clinical practice.